COMMUNIQUÉS West-GlobeNewswire

-
Adagene Reports Full Year 2024 Financial Results and Provides Corporate Update
24/03/2025 -
WATER III Randomized-Controlled Trial Results Announced at European Association of Urology Comparing Aquablation® Therapy to Laser Enucleation
24/03/2025 -
Cretostimogene Grenadenorepvec Data Continues to Demonstrate Best-in-Class Durability of Response as well as Consistent and Compelling Safety and Efficacy
24/03/2025 -
Clene Reports Full Year 2024 Financial Results and Recent Operating Highlights
24/03/2025 -
Daré Bioscience to Host Full Year 2024 Financial Results and Company Update Conference Call and Webcast on March 31, 2025
24/03/2025 -
Noah Medical’s Galaxy System Surpasses 5,000 Procedures, Marking a New Era in Robotic-Assisted Bronchoscopy
24/03/2025 -
Allarity Therapeutics Launches Comprehensive Effort to Combat Potential Illegal Naked Short Selling of Its Shares
24/03/2025 -
INmune Bio Inc. to Report Fourth Quarter 2024 Financial Results and Provide Corporate Update on March 27, 2025
24/03/2025 -
Alcon Agrees to Acquire LENSAR, Inc.
24/03/2025 -
HealthLynked Announces Enhanced Patient In-Office Booking and Upgrades to ARi Healthcare Assistant
24/03/2025 -
Axogen Announces Appointment of Rick Ditto as Vice President, Global Health Economics, Reimbursement & Policy, and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
24/03/2025 -
Tren-Max (Crazybulk) safe and legal steroid alternative to Trenbolone Acetate, Dosages Cycles Benefits and Guide to Buying Tren Ace, Tren Steroid For Sale!
24/03/2025 -
Biogen Announces Plans for New Global Headquarters and Innovation Hub in Kendall Square
24/03/2025 -
Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization
24/03/2025 -
BridgeBio to Present Cardiovascular Outcomes Data in Patients with Variant and Wild-type Transthyretin Amyloid Cardiomyopathy (ATTR-CM) from the ATTRibute-CM Study at the ACC Annual Scientific Sessions
24/03/2025 -
Pasithea Therapeutics to Present at the 2025 CAGLA NeauxCancer Conference
24/03/2025 -
Serina Therapeutics to Present at the American Chemistry Society (ACS) Spring 2025 Meeting
24/03/2025 -
The United Laboratories and Novo Nordisk announce exclusive license agreement for UBT251, a GLP-1/GIP/glucagon triple receptor agonist
24/03/2025 -
NativePath Native Hydrate: The Senior Hydration Solution That Supports Energy, Bladder Health & Brain Function
24/03/2025
Pages